Lv5
830 积分 2023-11-24 加入
Impact of systemic glucocorticoids on Gd‐IgA1 levels in immunoglobulin A Nephropathy: insights from the TESTING trial
8小时前
待确认
Efficacy and safety of a targeted‐release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2‐year results from a randomised phase 3 trial
8小时前
待确认
补体相关性肾病诊断 和治疗专家共识
9小时前
待确认
Targeted-release budesonide in recurrent IgA nephropathy after kidney transplantation
1天前
待确认
Post-transplant IgA nephropathy: a rapidly evolving field of kidney transplant medicine
2天前
已完结
Risk factors for IgA nephropathy recurrence and impact on graft survival in a cohort of kidney transplanted patients
2天前
已完结
Post-transplant IgA Nephropathy
2天前
求助中
A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy
5个月前
已完结
Efficacy and safety of ravulizumab in a phase 2 randomized controlled trial in IgA nephropathy
5个月前
已完结
Targeting APRIL in the Treatment of IgA Nephropathy
5个月前
已完结
皖公网安备34019202002308
